Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant
DOI: https://doi.org/10.2147/clep.s438013
2024-04-18
Clinical Epidemiology
Abstract:Lily G Bessette, 1 Daniel E Singer, 2 Ajinkya Pawar, 1 Vincent Wong, 1 Dae Hyun Kim, 1, 3, &ast Kueiyu Joshua Lin 1, 2, &ast 1 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; 2 Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 3 Marcus Institute for Aging Research, Hebrew Rehabilitation Center, Harvard Medical School, Boston, MA, USA &astThese authors contributed equally to this work Correspondence: Kueiyu Joshua Lin, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont St. Suite 3030, Boston, MA, 02120, USA, Tel +1 (617) 278-0930, Fax +1 (617) 232-8602, Email Background: High risk of intracranial hemorrhage (ICH) is a leading reason for withholding anticoagulation in patients with atrial fibrillation (AF). We aimed to develop a claims-based ICH risk prediction model in older adults with AF initiating oral anticoagulation (OAC). Methods: We used US Medicare claims data to identify new users of OAC aged ≥ 65 years with AF in 2010– 2017. We used regularized Cox regression to select predictors of ICH. We compared our AF ICH risk score with the HAS-BLED bleed risk and Homer fall risk scores by area under the receiver operating characteristic curve (AUC) and assessed net reclassification improvement (NRI) when predicting 1-year risk of ICH. Results: Our study cohort comprised 840,020 patients (mean [SD] age 77.5 [7.4] years and female 52.2%) split geographically into training (3963 ICH events [0.6%] in 629,804 patients) and validation (1397 ICH events [0.7%] in 210,216 patients) sets. Our AF ICH risk score, including 50 predictors, had superior AUCs of 0.653 and 0.650 in the training and validation sets than the HAS-BLED score of 0.580 and 0.567 ( p < 0.001) and the Homer score of 0.624 and 0.623 (p< 0.001). In the validation set, our AF ICH risk score reclassified 57.8%, 42.5%, and 43.9% of low, intermediate, and high-risk patients, respectively, by HAS-BLED score (NRI: 15.3%, p < 0.001). Similarly, it reclassified 0.0, 44.1, and 19.4% of low, intermediate, and high-risk patients, respectively, by the Homer score (NRI: 21.9%, p < 0.001). Conclusion: Our novel claims-based ICH risk prediction model outperformed the standard HAS-BLED score and can inform OAC prescribing decisions. Keywords: atrial fibrillation, anticoagulants, prediction modeling, prescriber decisions, AF Non-valvular Atrial fibrillation (AF) is highly prevalent in older adults (10% for those >80-years-old), 1 and it is associated with a five-fold increased risk of embolic stroke. 2 Anticoagulation can reduce this risk by 40–80%, but bleeding is its major complication. Clinical practice guidelines 3,4 recommend that AF patients with an estimated annual stroke risk 5,6 ≥2.2% receive an oral anticoagulant (OAC). Following this recommendation, a large majority of older adults with AF should receive an OAC. 7–9 However, nearly 50% of these patients are not anticoagulated, 10–12 with risk of falls being one of the most commonly cited reasons for withholding anticoagulation, primarily due to the fear of intracranial hemorrhage (ICH) following a fall. 10,13,14 There is limited evidence allowing prediction of ICH risk, particularly due to falls, in older AF patients taking OAC. The widely used and guideline recommended HAS-BLED score generates a risk of all-cause bleeding, where extracranial events predominate. 3,15 Indeed, HAS-BLED was developed on a dataset that included only 9 intracerebral hemorrhage events. As a result, it may not accurately predict risk of ICH and a dedicated ICH prediction tool is needed. 15 ICH events are generally far more likely to be fatal or disabling than extracranial bleeds and there are differences in their underlying mechanism. 16 Here, we report the development and validation of an ICH risk prediction model among adults aged 65 or older with non-valvular AF using a nationally representative sample of Medicare fee-for-service population. We compare our AF ICH risk prediction model's performance with the HAS-BLED score and the Homer score, a validated fall risk tool based on routinely collected clinical. 17 This retrospective cohort study using Medicare claims data was approved by the Institutional Review Board of the Brigham and Women's Hospital, Boston, Massachuse -Abstract Truncated-
public, environmental & occupational health